ChemEd (CHE) Q4 2025: Roto-Rooter Paid Leads Up 9.4% as Digital Mix Reshapes Margin Trajectory

2026-02-26 | By EarningsIQ Research

ChemEd’s fourth quarter exposed the operational strain of shifting lead generation economics at Roto-Rooter and a deliberate, margin-dilutive patient mix reset at VITAS. Management’s 2026 outlook hinges on commercial business expansion, digital marketing recalibration, and a return to higher-margin, longer-stay hospice admissions. Investors face a transition year defined by execution risk and margin normalization, not immediate recovery.

Summary

• Lead Generation Shift: Roto-Rooter’s paid digital leads rose sharply, but free (natural) leads fell, compressing margins.
• Patient Mix Reset: VITAS deliberately increased short-stay hospital admissions, trading near-term margin for Medicare cap relief.
• Execution-Weighted Second Half: Full-year growth and margin improvement are forecast to back-load into late 2026 as operational changes take hold.

Performance Analysis

Roto-Rooter faced a 3.7% revenue decline in Q4, with residential revenue dropping 3.1% and commercial revenue inching up 1.6%. The plumbing and excavation lines held steady or grew, but water restoration revenue fell 10.3% due to billing and collection headwinds. Paid digital leads increased 9.4% YoY, yet were offset by a similar decline in natural (organic) leads—leaving total lead volume flat and raising customer acquisition costs.

VITAS revenue grew 1.9%, but EBITDA margin compressed as short-stay hospital admissions surged to 44.8% of total admissions—a post-pandemic high. This mix shift, while reducing Florida Medicare cap liability by nearly $25 million, diluted revenue growth and profitability. Management began rebalancing toward longer-stay admissions in January, expecting incremental improvement through 2026.

• Digital Marketing Cost Escalation: Roto-Rooter’s paid lead cost stabilized at $90 per lead, but now comprises 60-65% of total leads, up from prior years.
• Write-off Spike: Water restoration write-offs rose 57% YoY in Q4, adding $11 million in annual write-off pressure, largely due to insurance AI-driven scrutiny and decentralized billing.
• Margin Compression: Roto-Rooter’s adjusted EBITDA margin fell 477 bps YoY, driven by higher marketing spend and water restoration write-offs.

Centralization of billing and a new SEO provider are expected to gradually improve Roto-Rooter’s lead generation and collections, but initial costs will weigh on H1 2026 results. Management repurchased 400,000 shares in Q4, returning capital despite operational turbulence.

Executive Commentary

Strategic Positioning

1. Roto-Rooter’s Digital Lead Transformation

Roto-Rooter’s business model—plumbing, water restoration, and drain cleaning—relies on consumer leads from digital channels. Google’s algorithm changes have sharply reduced free (organic) leads, forcing a pivot to paid channels. Paid leads, now the majority, cost $90 each and require 1.5 to 2 leads per paying job. This shift has raised customer acquisition costs and compressed margins, but is structurally necessary to maintain volume.

2. Centralization and Technology Investment

Billing and collections for water restoration work are being centralized and digitized, replacing inconsistent branch-level practices. This aims to counter rising insurance scrutiny—driven by AI—and recover up to half of 2025’s $11 million spike in write-offs. Initial transition costs will pressure H1 2026 results, but management expects a $4–6 million tailwind in H2.

3. VITAS Admissions Mix Management

VITAS’s core business—hospice and palliative care—requires balancing patient mix to optimize Medicare reimbursement and cap liability. The Q4 emphasis on hospital-based, short-stay admissions quickly eliminated Florida Medicare cap risk but suppressed margin and revenue. Leadership has now pivoted toward longer-stay admissions, which should gradually restore margin and census growth through 2026.

4. Commercial Sales Expansion

Roto-Rooter is expanding its commercial sales force, with branches employing dedicated commercial business managers seeing 10% higher revenue growth than others. Commercial customers offer more frequent, higher-value jobs and are less dependent on digital search, providing a buffer against consumer lead volatility.

5. Geographic Expansion and Regulatory Wins

VITAS secured a new certificate of need (CON) in Manatee County, Florida, unlocking access to a sizable new Medicare hospice population. This follows recent CON wins in three other Florida counties, with early results exceeding expectations. Regulatory expansion is a key lever for long-term census and revenue growth.

Key Considerations

This quarter marks a transition period where both subsidiaries are actively recalibrating their business models to address operational disruptions and margin pressure. Execution on digital, billing, and patient mix strategies will determine whether 2026 marks a return to normalized growth or continued volatility.

Key Considerations:

• Lead Mix Economics: The shift from free to paid digital leads at Roto-Rooter increases cost per job and compresses margins, requiring ongoing marketing efficiency gains.
• Billing Centralization: Water restoration revenue and collections depend on rapid adoption of centralized, technology-driven billing practices to counter insurance AI scrutiny.
• Patient Mix Normalization: VITAS must execute its pivot back to longer-stay admissions to restore margin and drive sustained census growth.
• Commercial Sales Force Impact: Early data suggest commercial business managers can drive meaningful revenue lift, but scale and productivity lag effects remain a watchpoint.
• Transition Year Weighting: Management forecasts 55% of 2026 earnings and EBITDA will be generated in the second half, heightening H2 execution risk.

Risks

Key risks include continued margin compression if digital lead costs rise faster than conversion rates improve, delayed or incomplete adoption of centralized billing processes, and slower-than-expected restoration of VITAS’s patient mix. Regulatory changes, further insurance scrutiny, or competitive responses from private equity-backed plumbing entrants could add volatility. Management’s guidance assumes operational normalization that remains unproven in the near term, especially given the magnitude of Q4’s miss.

Forward Outlook

For Q1 2026, ChemEd expects:

• Muted revenue and EBITDA as patient mix and billing changes are phased in
• Incremental improvement in lead generation and collections, with material gains expected later in the year

For full-year 2026, management guided:

• VITAS revenue growth of 5.5%–6.5% (prior to Medicare cap), with EBITDA margin of 17.5%–18%
• Roto-Rooter revenue growth of 3%–3.5%, with EBITDA margin of 22.5%–23%
• EPS of $23.25–$24.25 (adjusted)

Management emphasized that the majority of earnings and margin improvement is expected in the second half, as operational initiatives mature and patient mix normalizes.

• Centralized billing and new SEO provider expected to drive gradual revenue and margin gains
• Manatee County CON and commercial sales force expansion targeted for incremental growth

Takeaways

ChemEd’s Q4 results underscore the operational and margin headwinds of a business model in transition, with digital marketing costs and insurance-driven billing complexity reshaping both top and bottom lines.

• Margin Volatility: Both VITAS and Roto-Rooter sacrificed margin for strategic resets—VITAS to eliminate Medicare cap risk, Roto-Rooter to maintain volume via paid leads.
• Execution Risk: 2026 growth and margin improvement depend on successful implementation of centralized billing, patient mix normalization, and commercial sales expansion.
• Transition Year Watchpoints: Investors should monitor H2 2026 for evidence that operational changes are translating into improved profitability and sustainable growth, as guidance is heavily back-weighted.

Conclusion

ChemEd’s Q4 highlighted the cost and complexity of recalibrating legacy business models for a digital-first, regulated healthcare and home services landscape. Management’s confidence in a second-half recovery is credible but unproven, leaving investors with meaningful execution risk and a transition year narrative that will require close monitoring across digital, billing, and patient mix initiatives.

Industry Read-Through

ChemEd’s experience signals that digital lead generation cost inflation and insurance AI scrutiny are now structural realities for home services and healthcare providers alike. Plumbing, restoration, and hospice peers should anticipate further margin pressure as free digital visibility erodes and billing scrutiny intensifies. The shift to paid digital acquisition and centralized, technology-driven collections is likely to become industry standard. Regulatory expansion (via CON) remains a critical lever for growth in hospice, but operational discipline will separate winners from laggards in an environment where margin recovery is neither quick nor guaranteed.

CHE Industrials Home Services Digital Marketing Hospice Margin Patient Mix Collections